Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-11-14
2006-11-14
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253040, C514S303000, C544S117000, C544S362000, C546S120000
Reexamination Certificate
active
07135469
ABSTRACT:
The present application describes linear chain substituted monocyclic and bicyclic compounds and derivatives thereof of Formula I:in-line-formulae description="In-line Formulae" end="lead"?P4-P-M-M4Iin-line-formulae description="In-line Formulae" end="tail"?or pharmaceutically acceptable salt forms thereof, P-M are rings substituted by a linear group. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
REFERENCES:
patent: 6060491 (2000-05-01), Pruitt et al.
patent: WO 95/01980 (1995-01-01), None
patent: WO 02/057236 (2002-07-01), None
Duplantier, STN International (2006) HCAPLUS Database, Columbus, OH, Accession No. 1995:480325.
Bauer, K.A., “Fondaparinux: a new synthetic and selective inhibitor of Factor Xa”, Best Practice & Research Clinical Haematology, vol. 17, No. 1, pp. 89-104, 2004.
Gresele et al., “Novel approaches to the treatment of thrombosis”, TRENDS in Pharmacological Sciences, vol. 23, No. 1, pp. 25-32, Jan. 2002.
Linkins et al., “New Anticoagulants”, Seminars in Thrombosis and Hemostasis, vol. 29, No. 6, pp. 619-631, 2003.
Rauch et al., “Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences”, Annals of Internal Medicine, vol. 134, No. 3., pp. 224-238, Feb. 6, 2001.
Ruef et al., “New antithrombotic drugs on the horizon”, Expert Opin. Investig. Drugs, vol. 12, No. 5, pp. 781-797, 2003.
Weitz et al., “Thrombophilia and New Anticoagulant Drugs”, Hematology, pp. 424-438, 2004.
Bristol Myers Squibb Co.
Freistein Andrew B.
McKane Joseph K.
Sun Jing G.
Vance David H.
LandOfFree
Linear chain substituted monocyclic and bicyclic derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Linear chain substituted monocyclic and bicyclic derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Linear chain substituted monocyclic and bicyclic derivatives... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3698527